BiF-4 Insights – Deborah Brooks – Michael J. Fox Foundation
We want to de-risk ideas and help move them towards being taken into clinical trials.
We sometimes add money to company investments in order to make Phase 1 trials more robust than originally planned:
- $4 million VC-funded trial, we incremented by $750k to fund neuro-imaging and extra doctor visit
- In order to get more data out of the trial
We are almost filling the role of an early stage investor (in some cases).
Giving foundation money to drug companies must be a challenge for people giving money to the foundation to take, but we are pushing the envelope in order to do whatever we can to accelerate the finding of a cure.
For more information on the talk, go here.
NEVER MISS ANOTHER NEWSLETTER!
LATEST BLOGS
Eat, Sleep, Innovate: How to Make Creativity an Everyday Habit Inside Your Organization [Interview]
I had the opportunity recently to interview fellow author Jeff Gothelf to talk with him about his new book Sense and Respond, which is his second book with his co-author Josh Seiden and a major publisher. Congratulations Jeff! 1. Why is it so important that companies embed the two-way conversation with customers at the center of what they do?
Read More
Unexpected Foes – Weak Links in Innovation Roadmaps
Imagine you are implementing a transformation program in your organization. You have it all spelt out with the fashionable jargon…
Read More
